{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T16:52:38Z","timestamp":1784739158554,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.rceng.2026.502457","type":"journal-article","created":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:45:12Z","timestamp":1768715112000},"page":"502457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between Ehlers\u2013Danlos syndrome and mast cell activation syndrome: Is there scientific evidence?"],"prefix":"10.1016","volume":"226","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0439-8162","authenticated-orcid":false,"given":"J.A.","family":"Cuenca-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Dawid-Milner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"S\u00e1nchez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rceng.2026.502457_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2020.100077","article-title":"Ehlers\u2013Danlos syndrome: immunologic contrasts and connective tissue comparisons","volume":"4","author":"Islam","year":"2021","journal-title":"J Transl Autoimmun"},{"issue":"1","key":"10.1016\/j.rceng.2026.502457_bib0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ajmg.c.31552","article-title":"The 2017 international classification of the Ehlers\u2013Danlos syndromes","volume":"175","author":"Malfait","year":"2017","journal-title":"Am J Med Genet C Semin Med Genet."},{"issue":"1","key":"10.1016\/j.rceng.2026.502457_bib0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41572-020-0194-9","article-title":"The Ehlers\u2013Danlos syndromes","volume":"6","author":"Malfait","year":"2020","journal-title":"Nat Rev Dis Primers."},{"issue":"2","key":"10.1016\/j.rceng.2026.502457_bib0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1515\/dx-2020-0005","article-title":"Diagnosis of mast cell activation syndrome: a global \"consensus-2\"","volume":"8","author":"Afrin","year":"2021","journal-title":"Diagnosis (Berl)."},{"issue":"2","key":"10.1016\/j.rceng.2026.502457_bib0025","doi-asserted-by":"crossref","DOI":"10.5409\/wjcp.v13.i2.92813","article-title":"Mast cell activation syndrome: an up-to-date review of literature","volume":"13","author":"Ozdemir","year":"2024","journal-title":"World J Clin Pediatr."},{"issue":"4","key":"10.1016\/j.rceng.2026.502457_bib0030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12026-022-09280-1","article-title":"Association of mast-cell-related conditions with hypermobile syndromes: a review of the literature","volume":"70","author":"Monaco","year":"2022","journal-title":"Immunol Res."},{"issue":"3","key":"10.1016\/j.rceng.2026.502457_bib0035","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12016-019-08755-8","article-title":"The Relationship Between Hypermobile Ehlers\u2013Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS)","volume":"58","author":"Kucharik","year":"2020","journal-title":"Clin Rev Allergy Immunol."},{"key":"10.1016\/j.rceng.2026.502457_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2025.1513199","article-title":"Association of postural orthostatic tachycardia syndrome, hypermobility spectrum disorders, and mast cell activation syndrome in young patients; prevalence, overlap and response to therapy depends on the definition","volume":"16","author":"Yao","year":"2025","journal-title":"Front Neurol."},{"issue":"4","key":"10.1016\/j.rceng.2026.502457_bib0045","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.anai.2023.10.032","article-title":"Mast cells in the autonomic nervous system and potential role in disorders with dysautonomia and neuroinflammation","volume":"132","author":"Theoharides","year":"2024","journal-title":"Ann Allergy Asthma Immunol."},{"issue":"8","key":"10.1016\/j.rceng.2026.502457_bib0050","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.cgh.2025.02.015","article-title":"AGA clinical practice update on GI manifestations and autonomic or immune dysfunction in hypermobile Ehlers\u2013Danlos syndrome: expert review","volume":"23","author":"Aziz","year":"2025","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"4","key":"10.1016\/j.rceng.2026.502457_bib0055","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/ajmg.c.31951","article-title":"Dysautonomia in the Ehlers\u2013Danlos syndromes and hypermobility spectrum disorders-With a focus on the postural tachycardia syndrome","volume":"187","author":"Mathias","year":"2021","journal-title":"Am J Med Genet C Semin Med Genet."},{"key":"10.1016\/j.rceng.2026.502457_bib0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/B978-0-12-804766-8.00008-X","article-title":"Autonomic dysfunction: diagnosis and management","volume":"167","author":"Rafanelli","year":"2019","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"10.1016\/j.rceng.2026.502457_bib0065","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0022-3476(99)70173-3","article-title":"Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers\u2013Danlos syndrome","volume":"135","author":"Rowe","year":"1999","journal-title":"J Pediatr."},{"issue":"1","key":"10.1016\/j.rceng.2026.502457_bib0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9343(03)00235-3","article-title":"Dysautonomia in the joint hypermobility syndrome","volume":"115","author":"Gazit","year":"2003","journal-title":"Am J Med."},{"issue":"1","key":"10.1016\/j.rceng.2026.502457_bib0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.semarthrit.2013.12.006","article-title":"Dysautonomia and its underlying mechanisms in the hypermobility type of Ehlers\u2013Danlos syndrome","volume":"44","author":"De Wandele","year":"2014","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.rceng.2026.502457_bib0080","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9161865","article-title":"Orthostatic intolerance and postural orthostatic tachycardia syndrome in joint hypermobility syndrome\/Ehlers\u2013Danlos syndrome, hypermobility type: neurovegetative dysregulation or autonomic failure?","volume":"2017","author":"Celletti","year":"2017","journal-title":"Biomed Res Int."},{"issue":"12","key":"10.1016\/j.rceng.2026.502457_bib0085","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1002\/ajmg.a.62446","article-title":"Dysautonomia in hypermobile Ehlers\u2013Danlos syndrome and hypermobility spectrum disorders is associated with exercise intolerance and cardiac atrophy","volume":"185","author":"Ruiz Maya","year":"2021","journal-title":"Am J Med Genet A."},{"issue":"8","key":"10.1016\/j.rceng.2026.502457_bib0090","first-page":"481","article-title":"Hypermobile Ehlers\u2013Danlos syndrome and hypermobility spectrum disorders","volume":"103","author":"Yew","year":"2021","journal-title":"Am Fam Physician."},{"key":"10.1016\/j.rceng.2026.502457_bib0095","series-title":"GeneReviews [Internet]","first-page":"1993","article-title":"Hypermobile Ehlers-Danlos Syndrome","author":"Hakim","year":"2004"},{"issue":"1","key":"10.1016\/j.rceng.2026.502457_bib0100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13023-020-01470-0","article-title":"Multisystemic manifestations in a cohort of 75 classical Ehlers\u2013Danlos syndrome patients: natural history and nosological perspectives","volume":"15","author":"Ritelli","year":"2020","journal-title":"Orphanet J Rare Dis."},{"issue":"2","key":"10.1016\/j.rceng.2026.502457_bib0105","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/art.21557","article-title":"Clinical study of hereditary disorders of connective tissues in a Chilean population: joint hypermobility syndrome and vascular Ehlers\u2013Danlos syndrome","volume":"54","author":"Bravo","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.rceng.2026.502457_bib0110","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/ajmg.a.61523","article-title":"Clinical features, molecular results, and management of 12 individuals with the rare arthrochalasia Ehlers\u2013Danlos syndrome","volume":"182","author":"Ayoub","year":"2020","journal-title":"Am J Med Genet A."},{"issue":"4","key":"10.1016\/j.rceng.2026.502457_bib0115","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/ajmg.c.31957","article-title":"Variant connective tissue (joint hypermobility) and dysautonomia are associated with multimorbidity at the intersection between physical and psychological health","volume":"187","author":"Csecs","year":"2021","journal-title":"Am J Med Genet C Semin Med Genet."},{"issue":"12","key":"10.1016\/j.rceng.2026.502457_bib0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-066130","article-title":"Variant connective tissue (joint hypermobility) and its relevance to depression and anxiety in adolescents: a cohort-based case-control study","volume":"12","author":"Eccles","year":"2022","journal-title":"BMJ Open."},{"issue":"4","key":"10.1016\/j.rceng.2026.502457_bib0125","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ajmg.c.31955","article-title":"Updates on the psychological and psychiatric aspects of the Ehlers\u2013Danlos syndromes and hypermobility spectrum disorders","volume":"187","author":"Bulbena-Cabre","year":"2021","journal-title":"Am J Med Genet C Semin Med Genet."},{"issue":"4","key":"10.1016\/j.rceng.2026.502457_bib0130","first-page":"158","article-title":"Joint hypermobility syndrome and dysautonomia: expanding spectrum of disease presentation and manifestation","volume":"10","author":"Bohora","year":"2010","journal-title":"Indian Pacing Electrophysiol J."},{"issue":"5","key":"10.1016\/j.rceng.2026.502457_bib0135","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s00415-005-0056-0","article-title":"Recurrent neuropathy associated with Ehlers\u2013Danlos syndrome","volume":"253","author":"Voermans","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.rceng.2026.502457_bib0140","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1452409","article-title":"Hypermobile Ehlers\u2013Danlos syndrome and spontaneous CSF leaks: the connective tissue conundrum","volume":"15","author":"Severance","year":"2024","journal-title":"Front Neurol."},{"issue":"4","key":"10.1016\/j.rceng.2026.502457_bib0145","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ajmg.c.31944","article-title":"Some cases of hypermobile Ehlers\u2013Danlos syndrome may be rooted in mast cell activation syndrome","volume":"187","author":"Afrin","year":"2021","journal-title":"Am J Med Genet C Semin Med Genet."},{"key":"10.1016\/j.rceng.2026.502457_bib0150","first-page":"3","article-title":"Mast cells and basophils","volume":"16","author":"Schwartz","year":"2002","journal-title":"Clin Allergy Immunol."},{"issue":"4","key":"10.1016\/j.rceng.2026.502457_bib0155","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","article-title":"Mast cells and mastocytosis","volume":"112","author":"Metcalfe","year":"2008","journal-title":"Blood."},{"issue":"4","key":"10.1016\/j.rceng.2026.502457_bib0160","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ajmg.c.31940","article-title":"Mast cell activation disease and immunoglobulin deficiency in patients with hypermobile Ehlers\u2013Danlos syndrome\/hypermobility spectrum disorder","volume":"187","author":"Brock","year":"2021","journal-title":"Am J Med Genet C Semin Med Genet."},{"issue":"3","key":"10.1016\/j.rceng.2026.502457_bib0165","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MOG.0000000000001008","article-title":"Mast cell activation and nutritional disorders in patients with hypermobility","volume":"40","author":"Penny","year":"2024","journal-title":"Current opinion in gastroenterology"},{"issue":"3","key":"10.1016\/j.rceng.2026.502457_bib0170","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol."},{"issue":"4","key":"10.1016\/j.rceng.2026.502457_bib0175","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jaip.2019.01.006","article-title":"Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome","volume":"7","author":"Valent","year":"2019","journal-title":"J Allergy Clin Immunol Pract."},{"key":"10.1016\/j.rceng.2026.502457_bib0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2025.01.017","article-title":"How we treat mast cell activation syndrome","author":"Gulen","year":"2025","journal-title":"Ann Allergy Asthma Immunol."},{"issue":"6","key":"10.1016\/j.rceng.2026.502457_bib0185","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.ajpath.2013.02.013","article-title":"Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: role of transmembrane SCF and the PAR-2\/PKC-alpha\/Raf-1\/p44\/42 signaling pathway","volume":"182","author":"Wygrecka","year":"2013","journal-title":"Am J Pathol."},{"issue":"3","key":"10.1016\/j.rceng.2026.502457_bib0190","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1365-2567.2000.00973.x","article-title":"Mast cells enhance contraction of three-dimensional collagen lattices by fibroblasts by cell-cell interaction: role of stem cell factor\/c-kit","volume":"99","author":"Yamamoto","year":"2000","journal-title":"Immunology."},{"key":"10.1016\/j.rceng.2026.502457_bib0195","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1466491","article-title":"Mast cells: a double-edged sword in inflammation and fibrosis","volume":"12","author":"Wang","year":"2024","journal-title":"Front Cell Dev Biol."},{"issue":"24","key":"10.1016\/j.rceng.2026.502457_bib0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249673","article-title":"A review of the evidence for and against a role for mast cells in cutaneous scarring and fibrosis","volume":"21","author":"Wilgus","year":"2020","journal-title":"Int J Mol Sci."},{"issue":"5","key":"10.1016\/j.rceng.2026.502457_bib0205","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.4049\/jimmunol.180.5.3543","article-title":"Mast cell-fibroblast interactions induce matrix metalloproteinase-9 release from fibroblasts: role for IgE-mediated mast cell activation","volume":"180","author":"Abel","year":"2008","journal-title":"J Immunol."},{"issue":"3","key":"10.1016\/j.rceng.2026.502457_bib0210","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.0022-202x.2001.01705.x","article-title":"Mast cell-fibroblast interactions: human mast cells as source and inducers of fibroblast and epithelial growth factors","volume":"118","author":"Artuc","year":"2002","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.rceng.2026.502457_bib0215","article-title":"The mast cell exosome-fibroblast connection: a novel pro-fibrotic pathway","volume":"10","author":"Savage","year":"2023","journal-title":"Front Med (Lausanne)."},{"issue":"24","key":"10.1016\/j.rceng.2026.502457_bib0220","doi-asserted-by":"crossref","DOI":"10.3390\/cells11244040","article-title":"RNA-Seq of dermal fibroblasts from patients with hypermobile Ehlers\u2013Danlos syndrome and hypermobility spectrum disorders supports their categorization as a single entity with involvement of extracellular matrix degrading and proinflammatory pathomechanisms","volume":"11","author":"Ritelli","year":"2022","journal-title":"Cells."},{"issue":"3","key":"10.1016\/j.rceng.2026.502457_bib0225","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5213\/inj.2015.19.3.142","article-title":"Interleukin-33 and mast cells bridge innate and adaptive immunity: from the allergologist\u2019s perspective","volume":"19","author":"Jang","year":"2015","journal-title":"Int Neurourol J."},{"key":"10.1016\/j.rceng.2026.502457_bib0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.963444","article-title":"Cardiac mast cells: a two-head regulator in cardiac homeostasis and pathogenesis following injury","volume":"13","author":"Jin","year":"2022","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.rceng.2026.502457_bib0235","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol Cancer."},{"issue":"4","key":"10.1016\/j.rceng.2026.502457_bib0240","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/thx.40.4.300","article-title":"Abnormalities of the lungs and thoracic cage in the Ehlers\u2013Danlos syndrome","volume":"40","author":"Ayres","year":"1985","journal-title":"Thorax."},{"issue":"10","key":"10.1016\/j.rceng.2026.502457_bib0245","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/ard.2006.062224","article-title":"Asthma and airways collapse in two heritable disorders of connective tissue","volume":"66","author":"Morgan","year":"2007","journal-title":"Ann Rheum Dis."},{"issue":"2","key":"10.1016\/j.rceng.2026.502457_bib0250","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jaci.2013.02.030","article-title":"High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders","volume":"132","author":"Abonia","year":"2013","journal-title":"J Allergy Clin Immunol."},{"issue":"1","key":"10.1016\/j.rceng.2026.502457_bib0255","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/jpn3.12245","article-title":"High prevalence of gastrointestinal disorders in a large cohort of patients with joint hypermobility","volume":"79","author":"Sood","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr."},{"issue":"1","key":"10.1016\/j.rceng.2026.502457_bib0260","first-page":"49","article-title":"Systemic manifestations of Ehlers\u2013Danlos syndrome","volume":"34","author":"Song","year":"2020","journal-title":"Proc (Bayl Univ Med Cent)."},{"key":"10.1016\/j.rceng.2026.502457_bib0265","first-page":"143","article-title":"Ehlers\u2013Danlos syndrome is associated with Idiopathic Urticaria-a retrospective study [abstract]","author":"Szalewski","year":"2019","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.rceng.2026.502457_bib0270","doi-asserted-by":"crossref","DOI":"10.1016\/S0091-6749(00)91374-5","article-title":"Collagen changes in cases of hypermobility syndrome (HMS) with rhino-sinusitis: a light and ultrastructural microscopic study [abstract]","author":"Fouda","year":"2000","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.rceng.2026.502457_bib0275","first-page":"39","article-title":"Joint hypermobility and joint hypermobility syndrome in Iraqi patients with asthma","volume":"2","author":"Al-Rawi","year":"2012","journal-title":"Int J Modern Biol Med."},{"issue":"9","key":"10.1016\/j.rceng.2026.502457_bib0280","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/ajmg.a.34134","article-title":"Screening for celiac disease in the joint hypermobility syndrome\/Ehlers\u2013Danlos syndrome hypermobility type","volume":"155A","author":"Danese","year":"2011","journal-title":"Am J Med Genet A."},{"issue":"9","key":"10.1016\/j.rceng.2026.502457_bib0285","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1002\/ajmg.a.35506","article-title":"Gynecologic and obstetric implications of the joint hypermobility syndrome (a.k.a. Ehlers\u2013Danlos syndrome hypermobility type) in 82 Italian patients","volume":"158A","author":"Castori","year":"2012","journal-title":"Am J Med Genet A"},{"issue":"1","key":"10.1016\/j.rceng.2026.502457_bib0290","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13023-016-0511-2","article-title":"Gynecologic symptoms and the influence on reproductive life in 386 women with hypermobility type Ehlers\u2013Danlos syndrome: a cohort study","volume":"11","author":"Hugon-Rodin","year":"2016","journal-title":"Orphanet J Rare Dis."},{"issue":"3","key":"10.1016\/j.rceng.2026.502457_bib0295","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/AOG.0000000000000123","article-title":"Obstetric and gynecologic challenges in women with Ehlers\u2013Danlos syndrome","volume":"123","author":"Hurst","year":"2014","journal-title":"Obstet Gynecol."},{"issue":"1-2","key":"10.1016\/j.rceng.2026.502457_bib0300","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2014.03.002","article-title":"Ehlers\u2013Danlos syndrome and Postural Tachycardia syndrome: a relationship study","volume":"340","author":"Wallman","year":"2014","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.rceng.2026.502457_bib0305","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrneurol.2011.187","article-title":"Postural tachycardia syndrome--current experience and concepts","volume":"8","author":"Mathias","year":"2011","journal-title":"Nat Rev Neurol."},{"key":"10.1016\/j.rceng.2026.502457_bib0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2025.03.022","article-title":"Prevalence of mast cell activation disorders and hereditary alpha tryptasemia among patients with postural orthostatic tachycardia syndrome and Ehlers-Danlos syndrome: a systematic review","author":"Farley","year":"2025","journal-title":"Ann Allergy Asthma Immunol."},{"issue":"6","key":"10.1016\/j.rceng.2026.502457_bib0315","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.anai.2020.08.015","article-title":"Cosegregation of postural orthostatic tachycardia syndrome, hypermobile Ehlers\u2013Danlos syndrome, and mast cell activation syndrome","volume":"125","author":"Vadas","year":"2020","journal-title":"Ann Allergy Asthma Immunol."},{"issue":"2","key":"10.1016\/j.rceng.2026.502457_bib0320","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11882-024-01126-0","article-title":"Using the right criteria for MCAS","volume":"24","author":"Gulen","year":"2024","journal-title":"Curr Allergy Asthma Rep."},{"issue":"12","key":"10.1016\/j.rceng.2026.502457_bib0325","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/all.13226","article-title":"Validation of international consensus equation for acute serum total tryptase in mast cell activation: a perioperative perspective","volume":"72","author":"Baretto","year":"2017","journal-title":"Allergy."},{"issue":"13-14","key":"10.1016\/j.rceng.2026.502457_bib0330","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.clinbiochem.2016.02.007","article-title":"Analytical and clinical validation of an LC-MS\/MS method for urine leukotriene E4: a marker of systemic mastocytosis","volume":"49","author":"Lueke","year":"2016","journal-title":"Clin Biochem."},{"issue":"3","key":"10.1016\/j.rceng.2026.502457_bib0335","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.iac.2018.04.011","article-title":"Mast cell mediators of significance in clinical practice in mastocytosis","volume":"38","author":"Butterfield","year":"2018","journal-title":"Immunol Allergy Clin North Am."},{"issue":"8","key":"10.1016\/j.rceng.2026.502457_bib0340","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.jaip.2022.03.008","article-title":"Nontryptase urinary and hematologic biomarkers of mast cell expansion and mast cell activation: status 2022","volume":"10","author":"Butterfield","year":"2022","journal-title":"J Allergy Clin Immunol Pract."},{"issue":"4","key":"10.1016\/j.rceng.2026.502457_bib0345","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00418-019-01803-6","article-title":"Mast cell chymase: morphofunctional characteristics","volume":"152","author":"Atiakshin","year":"2019","journal-title":"Histochem Cell Biol."},{"issue":"3","key":"10.1016\/j.rceng.2026.502457_bib0350","doi-asserted-by":"crossref","DOI":"10.3390\/cells11030570","article-title":"Carboxypeptidase A3-A key component of the protease phenotype of mast cells","volume":"11","author":"Atiakshin","year":"2022","journal-title":"Cells."},{"issue":"3","key":"10.1016\/j.rceng.2026.502457_bib0355","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.amjms.2016.12.013","article-title":"Characterization of mast cell activation syndrome","volume":"353","author":"Afrin","year":"2017","journal-title":"Am J Med Sci."},{"issue":"10","key":"10.1016\/j.rceng.2026.502457_bib0360","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.3390\/cimb46100689","article-title":"Decoding the genetic basis of mast cell hypersensitivity and infection risk in hypermobile Ehlers\u2013Danlos syndrome","volume":"46","author":"Shirvani","year":"2024","journal-title":"Curr Issues Mol Biol."}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2254887426000147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2254887426000147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:40:24Z","timestamp":1770741624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2254887426000147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2254887426000147"],"URL":"https:\/\/doi.org\/10.1016\/j.rceng.2026.502457","relation":{},"ISSN":["2254-8874"],"issn-type":[{"value":"2254-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between Ehlers\u2013Danlos syndrome and mast cell activation syndrome: Is there scientific evidence?","name":"articletitle","label":"Article Title"},{"value":"Revista Cl\u00ednica Espa\u00f1ola (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rceng.2026.502457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rce.2025.502457","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Medicina Interna (SEMI). All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502457"}}